Status report on carbapenemases: challenges and prospects

Author(s): Patel G, Bonomo RA


Antimicrobial resistance in hospital and community-onset bacterial infections is a significant source of patient morbidity and mortality. In the past decade, we have witnessed the increasing recovery of carbapenem-resistant Gram-negative bacteria. For many isolates, carbapenem resistance is due to the production of carbapenemases, β-lactamases that can inactivate carbapenems and frequently other β-lactam antibiotics. Currently, these enzymes are mainly found in three different β-lactamase classes (class A, B and D). Regardless of the molecular classification, there are few antimicrobials available to treat infections with these organisms and data regarding agents in development are limited to in vitro studies. This article focuses on the epidemiology of carbapenemase-producing Gram-negative bacteria. We also review available agents and those in development with potential activity against this evolving threat.

Similar Articles


Author(s): Queenan AM, Bush K

Interspecies spread of Klebsiella pneumoniae carbapenemase gene in a single patient

Author(s): Sidjabat HE, Silveira FP, Potoski BA, Abu-Elmagd KM, Adams- Haduch JM, et al.

Emergence of Novel Plasmid-mediated Beta-lactamase in klebsiella pneumoniae

Author(s): Fallah F, Hakemi Vala M, Hashemi A, Shams S

Global spread of carbapenemase producing Enterobacteriaceae

Author(s): Nordmann P, Naas T, Poirel L

A study on prevalence of KPC producing from Klebsiella pneumoniae using Modified Hodge Test and CHRO Magar in Iran

Author(s): Haji Hashemi B, Farzanehkhah M, Dolatyar A, Imani M, Farzami MR, et al.

Multiplex PCR amplification assay for the detection of blaSHV, blaTEM and blaCTX-M genes in Enterobacteriaceae

Author(s): Monstein HJ, Östholm-Balkhed A, Nilsson MV, Nilsson M, Dornbusch K, et al.